Sharon Bio-Medicine informs about Outcome of Board Meeting

10 Jun 2015 Evaluate

Sharon Bio-Medicine has informed that the Board of Directors of the Company at its meeting held on June 10, 2015, has approved the allotment of 66,51,300 equity shares of Rs 2 each at a premium of Rs 48 per share to the allottees, upon their exercise of option to convert the convertible warrants into equity shares.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.